HDAC9 and neoplasm: HDAC inhibitors are a new class of cytostatic agents that inhibit the proliferation of tumor cells in culture and in vivo by inducing cell cycle arrest, differentiation and apoptosis and may be of potential use in the treatment of cervical cancer [20].